Breast Cancer Prognostic Biomarkers: Transcriptome & Proteome Analysis

By A Mystery Man Writer
Last updated 04 Jun 2024
Breast Cancer Prognostic Biomarkers: Transcriptome & Proteome Analysis
Integrating the transcriptome and proteome reveals two prognostic biomarkers for breast cancer, particularly for the estrogen receptor positive subset.
Breast Cancer Prognostic Biomarkers: Transcriptome & Proteome Analysis
Biomarkers in drug discovery and development
Breast Cancer Prognostic Biomarkers: Transcriptome & Proteome Analysis
PDF) Identification of prognostic biomarkers for suppressing tumorigenesis and metastasis of Hepatocellular carcinoma through transcriptome analysis
Breast Cancer Prognostic Biomarkers: Transcriptome & Proteome Analysis
Cells, Free Full-Text
Breast Cancer Prognostic Biomarkers: Transcriptome & Proteome Analysis
Identification of blood protein biomarkers for breast cancer staging by integrative transcriptome and proteome analyses - ScienceDirect
Breast Cancer Prognostic Biomarkers: Transcriptome & Proteome Analysis
Frontiers Integrated Transcriptome and Pathway Analyses Revealed Multiple Activated Pathways in Breast Cancer
Breast Cancer Prognostic Biomarkers: Transcriptome & Proteome Analysis
Breast Cancer Prognostic Biomarkers: Transcriptome & Proteome Analysis
Breast Cancer Prognostic Biomarkers: Transcriptome & Proteome Analysis
Cancers, Free Full-Text
Breast Cancer Prognostic Biomarkers: Transcriptome & Proteome Analysis
Identification of Prognostic Biomarkers for Glioblastoma Based on Transcriptome and Proteome Association Analysis - Jiabin Wang, Shi Yan, Xiaoli Chen, Aowen Wang, Zhibin Han, Binchao Liu, Hong Shen, 2022
Breast Cancer Prognostic Biomarkers: Transcriptome & Proteome Analysis
New Clues to Prognostic Biomarkers of Four Hematological Malignancies
Breast Cancer Prognostic Biomarkers: Transcriptome & Proteome Analysis
Breast cancer metastasis: Is it a matter of OMICS and proper ex-vivo models? - Computational and Structural Biotechnology Journal

© 2014-2024 academicdiary.news. All rights reserved.